Published in Bull World Health Organ on January 01, 1987
Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother (2004) 4.54
Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev (2009) 3.41
Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci U S A (2013) 1.57
Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa. BMJ (1993) 1.30
Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ (1989) 1.03
The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis. Br J Clin Pharmacol (1995) 1.02
Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial. Am J Trop Med Hyg (2015) 0.91
Concentrations of chloroquine and malaria parasites in blood in Nigerian children. Antimicrob Agents Chemother (2000) 0.85
Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial. PLoS One (2014) 0.84
Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis. Am J Trop Med Hyg (2011) 0.82
Changing patterns of malaria in south-east Scotland: implications for practitioner awareness and prophylactic advice. Postgrad Med J (1992) 0.79
Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr (1983) 2.28
Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol (1981) 2.03
Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J Chromatogr (1983) 1.99
The concentration of chloroquine in serum during short and long term malaria prophylaxis with standard and 'double' dosage in non-immunes: clinical implications. Ann Trop Med Parasitol (1979) 1.51
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum. Trop Med Parasitol (1986) 1.22
Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr (1983) 2.28
Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol (1981) 2.03
Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis (2002) 2.02
[Tetanus with a deep wound?]. Lakartidningen (1994) 1.92
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop (2003) 1.80
Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health (1996) 1.65
The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol (1984) 1.65
Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Trans R Soc Trop Med Hyg (1992) 1.63
The concentration of chloroquine in serum during short and long term malaria prophylaxis with standard and 'double' dosage in non-immunes: clinical implications. Ann Trop Med Parasitol (1979) 1.51
Are white blood cell count, platelet count, erythrocyte sedimentation rate and C-reactive protein useful in the diagnosis of septicaemia and endocarditis? Scand J Infect Dis (1986) 1.44
Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatography. J Chromatogr (1980) 1.43
[False safety with homeopathic agents. Swedes became ill with malaria in spite of prophylaxis]. Lakartidningen (1995) 1.38
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop. J Travel Med (2003) 1.27
Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. J Pharm Biomed Anal (2007) 1.27
A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and beta-thalassaemia traits. Ann Trop Med Parasitol (1983) 1.24
Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum. Trop Med Parasitol (1986) 1.22
Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper. Ther Drug Monit (1985) 1.21
Changes in erythrocyte sedimentation rate, C-reactive protein and hematological parameters in patients with acute malaria. Scand J Infect Dis (1989) 1.20
Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction. Bull World Health Organ (1985) 1.19
Different malaria control activities in an area of Liberia--effects on malariometric parameters. Ann Trop Med Parasitol (1985) 1.19
Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma. J Pharm Biomed Anal (2005) 1.15
Improved method for analysis of glycated haemoglobin by ion exchange chromatography. Ann Clin Biochem (1994) 1.13
Parenteral chloroquine for treating falciparum malaria. J Infect Dis (1987) 1.09
A new approach to evaluate stability of amodiaquine and its metabolite in blood and plasma. J Pharm Biomed Anal (2005) 1.09
Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis. Br Med J (Clin Res Ed) (1987) 1.08
Effect of different fractions of heparin on Plasmodium falciparum merozoite invasion of red blood cells in vitro. Am J Trop Med Hyg (1992) 1.08
Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit (1985) 1.05
The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza. Scand J Infect Dis (1989) 1.04
Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ (1989) 1.03
Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1981) 1.02
Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene Pfmdr1. Trans R Soc Trop Med Hyg (1996) 1.01
Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid. J Infect Dis (1979) 1.01
Automated solid-phase extraction method for the determination of piperaquine in capillary blood applied onto sampling paper by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.01
Sulfadoxine assay using capillary blood samples dried on filter paper--suitable for monitoring of blood concentrations in the field. Ther Drug Monit (1987) 1.00
Painless venepuncture in the field. Trans R Soc Trop Med Hyg (1991) 1.00
Characterization of human urinary metabolites of the antimalarial piperaquine. Drug Metab Dispos (2006) 0.99
Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Trans R Soc Trop Med Hyg (1991) 0.98
Improved validated assay for the determination of mefloquine and its carboxy metabolite in plasma, serum and whole blood using solid-phase extraction and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1999) 0.98
Evaluation of three qualitative tests for detection of chloroquine in urine--agreement with plasma concentrations determined with liquid chromatography. Ann Trop Med Parasitol (1986) 0.98
Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations. Pharmacogenetics (1999) 0.97
Automated solid-phase extraction method for the determination of piperaquine in whole blood by rapid liquid chromatography. Ther Drug Monit (2003) 0.97
Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar). Br Med J (Clin Res Ed) (1984) 0.97
Reliability of Dill-Glazko test. Lancet (1985) 0.97
Malaria parasites and chloroquine concentrations in Tanzanian schoolchildren. Trop Med Parasitol (1994) 0.96
Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol (2004) 0.96
Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine. Bull World Health Organ (1994) 0.94
Comparison of 3, 5 and 7 days' treatment with Quinimax for falciparum malaria in Guinea-Bissau. Trans R Soc Trop Med Hyg (1997) 0.94
An improved gas chromatographic method for the simultaneous determination of chloroquine and two metabolites using capillary columns. J Chromatogr (1984) 0.94
The working capacity of Liberian males: a comparison between urban and rural populations in relation to malaria. Ann Trop Med Parasitol (1981) 0.92
Susceptibility of Plasmodium falciparum to quinine in vitro: effects of drug concentrations and time of exposure. Trans R Soc Trop Med Hyg (1995) 0.92
High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr (1988) 0.92
Simultaneous determination of pyrimethamine and sulphadoxine in human plasma by high-performance liquid chromatography. Trans R Soc Trop Med Hyg (1985) 0.91
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clin Pharmacol Ther (1999) 0.91
EBV specific killer T cells and serologic responses after onset of infectious mononucleosis. J Clin Lab Immunol (1978) 0.90
Improving lactate analysis with the YSI 2300 GL: hemolyzing blood samples makes results comparable with those for deproteinized whole blood. Clin Chem (1992) 0.90
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Afr Health Sci (2006) 0.90
Standard and reduced doses of mefloquine for treatment of Plasmodium falciparum in Tanzania: whole blood concentrations in relation to adverse reactions, in vivo response, and in vitro susceptibility. Am J Trop Med Hyg (1991) 0.90
Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis. Trans R Soc Trop Med Hyg (1990) 0.89
Is chloroquine-resistant Plasmodium falciparum malaria emerging in Senegal or The Gambia? Trans R Soc Trop Med Hyg (1987) 0.89
Does chloroquine contribute to the risk of serious adverse reactions to fansidar? Lancet (1985) 0.89
Monthly antimalarial chemotherapy to children in a holoendemic area of Liberia. Ann Trop Med Parasitol (1986) 0.88
Enantioselective pharmacokinetics of mefloquine during long-term intake of the prophylactic dose. Br J Clin Pharmacol (1997) 0.87
Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria. Antimicrob Agents Chemother (1991) 0.87
Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects. Eur J Clin Pharmacol (1986) 0.87
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation. Acta Trop (2006) 0.86
Chloroquine resistant Plasmodium falciparum malaria in Guinea-Bissau. Trans R Soc Trop Med Hyg (1991) 0.86
Concentrations of chloroquine and malaria parasites in blood in Nigerian children. Antimicrob Agents Chemother (2000) 0.85
Evidence for a reduced effect of chloroquine against Plasmodium falciparum in alpha-thalassaemic children. Trop Med Int Health (2001) 0.85
Long-term exposure of Trypanosoma brucei gambiense to pentamidine in vitro. Trans R Soc Trop Med Hyg (1994) 0.84
Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine. J Pharm Biomed Anal (2005) 0.84
Intestinal parasites in refugees and asylum seekers entering the Stockholm area, 1987-88: evaluation of routine stool screening. Scand J Infect Dis (1994) 0.83
Integrating decision support, based on the Arden Syntax, in a clinical laboratory environment. Proc Annu Symp Comput Appl Med Care (1993) 0.83
Mass proguanil prophylaxis. Lancet (1987) 0.83
A new approach to evaluate regression models during validation of bioanalytical assays. J Pharm Biomed Anal (2005) 0.83
Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania. Ann Trop Med Parasitol (1986) 0.82
Chloroquine intoxication. Br J Clin Pharmacol (1983) 0.82
Plasma pentamidine concentrations vary between individuals with Pneumocystis carinii pneumonia and the drug is actively secreted by the kidney. J Antimicrob Chemother (1994) 0.82
Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil. J Infect Dis (1999) 0.82
Malaria prophylaxis and epilepsy. BMJ (1988) 0.81
High-performance liquid chromatographic method for the enantioselective analysis of mefloquine in plasma and urine. J Chromatogr B Biomed Appl (1994) 0.81
Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized. Trop Med Int Health (1998) 0.81
Improved sample collection technique for capillary blood on filter paper for determination of glycated haemoglobin. Ann Clin Biochem (1989) 0.81
Automated solid-phase extraction method for the determination of piperaquine in plasma by peak compression liquid chromatography. J Chromatogr Sci (2003) 0.81
Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness. Br J Clin Pharmacol (1995) 0.80
Further support for changes in chloroquine disposition and metabolism between a low and a high dose. Eur J Clin Pharmacol (1985) 0.80
Plasma concentrations of sulfadoxine-pyrimethamine, mefloquine and its main metabolite after regular malaria prophylaxis for two years. Trans R Soc Trop Med Hyg (1991) 0.80